Intraocular Stent Retention and Flow Path Design for Glaucoma Drainage

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing intraocular stents face challenges with insertion and stability issues, as well as clotting and debris clogging, leading to disrupted aqueous humor flow and increased intraocular pressure, often requiring invasive surgical incisions for insertion.

Innovation Solution

Intraocular stents with a self-piercing harpoon and retention members that engage the trabecular meshwork and canal of Schlemm, providing stable retention and non-perpendicular fluid flow paths, reducing the need for separate incisions and minimizing clotting and debris buildup.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If a self-piercing harpoon structure is used for insertion, then surgical invasiveness is reduced and insertion ease is improved, but device complexity increases due to the specialized piercing mechanism

Engineering Contradiction:
Improveinsertion easeVSAvoiddevice complexity
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The stent is equipped with a self-piercing harpoon that automatically penetrates the trabecular meshwork and canal of Schlemm wall without requiring a separate surgical incision or cutting device. The harpoon structure enables the device to perform its own insertion function, reducing surgical invasiveness while the integrated design manages the added complexity.

Inventive Principle:
Principle #25Self-service

2Reliability

If retention members are added to engage trabecular meshwork and canal of Schlemm, then stent stability is improved, but device complexity increases

Engineering Contradiction:
Improvestent stabilityVSAvoiddevice complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The retention members are integrated with the stent structure itself, combining the anchoring function with the main body of the device. This merging approach provides stable engagement with the trabecular meshwork and canal of Schlemm while avoiding the need for separate retention components, thus managing device complexity.

Inventive Principle:
Principle #5Merging (Combining)

3Reliability

If non-perpendicular fluid flow paths are designed, then clotting and debris buildup is reduced, but manufacturing precision requirements increase

Engineering Contradiction:
Improveclotting resistanceVSAvoidmanufacturing precision
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The fluid flow path angle is changed from a perpendicular (90-degree) configuration to a non-perpendicular angle. This parameter modification reduces clotting and debris buildup by improving fluid dynamics, while the specific angle chosen balances the benefit against manufacturing precision requirements.

Inventive Principle:
Principle #35Parameter changes

4Productivity

If the stent is designed to extend between anterior chamber and canal of Schlemm, then aqueous humor drainage efficiency is improved, but device complexity increases due to multiple engagement points

Engineering Contradiction:
Improvedrainage efficiencyVSAvoiddevice complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The stent is designed as a multi-functional device that simultaneously performs aqueous humor drainage, self-piercing insertion, and stable retention through integrated features. The single structure accomplishes multiple functions (drainage conduit, piercing harpoon, retention members), reducing the need for separate components and managing overall device complexity while maximizing drainage efficiency.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentEP4370079B1Intraocular stent
Publication Date: 2026.04.08 NEW WORLD MEDICAL INC
  • EP4370079B1 patent drawingFigure 1~2
  • EP4370079B1 patent drawingFigure 3~4
  • EP4370079B1 patent drawingFigure 5~6

AI summary

Intraocular stents are provided. An intraocular stent (20) includes a piercing end (40) for penetration into portions of the eye without requiring a surgical incision by a separate cutting device. A first retention member (50) stabilizes the intraocular stent (20) against the anterior wall of the canal of Schlemm. A second retention member (60) stabilizes the intraocular stent within the trabecular meshwork. A fluid inlet end (73) is configured to be disposed within the anterior chamber. In use, aqueous humor fluid flows into the fluid inlet end (72) through a central lumen (70) and/or drainage tubes (80) and out into the canal of Schlemm. Stack configurations of intraocular stents and insertion devices are also provided.